Adalimumab for Mooren's ulcer.
Cordero-Coma
Miguel
M
Benito
Manuel Franco
MF
Fuertes
Carlos Lobato
CL
Antolín
Sara Calleja
SC
García Ruíz
José M
JM
D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003320:Corneal Ulcer / Q000188:drug therapy*; D005260:Female; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology; D014792:Visual Acuity
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab